There could be a further window of opportunity: FY22 numbers.
Currently the market is expecting EPS of around 30c for FY21, but the market is expecting that number to increase to 38c by FY22.
I think with the delays in vaccinations, that FY22 actuals could disappoint.
Updated outlooks could occur in October in preparation for the Nov AGM.
I think first half FY22 could disappoint.
If updated outlooks really disappoint consensus expectations (remembering that by Oct/Nov, consensus is for earnings growth of more than 20% in FY 22, so stable numbers will not meet consensus), then despair will really settle in, and this will present an incredible opportunity for long term entry.
There could be a further window of opportunity: FY22...
-
- There are more pages in this discussion • 6,442 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.952B | |||
| Open | High | Low | Value | Volume |
| $6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 18844 | $6.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.85 | 41602 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |